{"id":"azd5423","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":{"chemblId":"CHEMBL4072756","moleculeType":"Small molecule","molecularWeight":"487.45"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"CD73 is an enzyme involved in the production of adenosine, which plays a role in immune suppression. By inhibiting CD73, AZD5423 aims to reduce adenosine levels and enhance anti-tumor immune responses.","oneSentence":"AZD5423 is a small molecule inhibitor of the CD73 enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:57:42.143Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Metastatic non-small cell lung cancer, PD-L1 positive"}]},"trialDetails":[{"nctId":"NCT01225549","phase":"PHASE2","title":"The Study Will Evaluate the Efficacy of AZD5423 in Patients With Mild Asthma Challenged With an Inhaled Allergen","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-11","conditions":"Asthma","enrollment":27},{"nctId":"NCT01310322","phase":"PHASE1","title":"A Study in Healthy Subjects and Mild Asthmatics to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-04","conditions":"Healthy, Asthma","enrollment":12},{"nctId":"NCT01338350","phase":"PHASE1","title":"Safety, Pharmacokinetics and Pharmacodynamics After Single and Multiple Dosing of AZD5423 in Japanese Healthy Male Subjects","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2011-06","conditions":"Healthy","enrollment":96},{"nctId":"NCT01635985","phase":"PHASE1","title":"A Study in Healthy Subjects to Investigate Pharmacokinetics of AZD5423 When Administered in Different Ways","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-08","conditions":"Bioavailability and AUC","enrollment":18},{"nctId":"NCT01037504","phase":"PHASE1","title":"AZD5423 Multiple Ascending Dose Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2010-01","conditions":"Healthy","enrollment":27},{"nctId":"NCT00963183","phase":"PHASE1","title":"AZD5423 Single Ascending Dose Study","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2009-08","conditions":"Healthy Volunteers","enrollment":72},{"nctId":"NCT01555099","phase":"PHASE2","title":"Multi-centre Study to Assess the Efficacy and Safety of AZD5423 in COPD Patients on a Background Therapy of Formoterol","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2012-04","conditions":"Chronic Obstructive Pulmonary Disease (COPD)","enrollment":353}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AZD5423","genericName":"AZD5423","companyName":"AstraZeneca","companyId":"astrazeneca","modality":"Small molecule","firstApprovalDate":"","aiSummary":"AZD5423 is a small molecule inhibitor of the CD73 enzyme. Used for Metastatic non-small cell lung cancer, PD-L1 positive.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}